{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Rockford",
      "address_1": "1718 Northrock Ct",
      "reason_for_recall": "Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer",
      "address_2": "",
      "product_quantity": "408 cartons",
      "code_info": "Batch 3096049",
      "center_classification_date": "20180822",
      "distribution_pattern": "Nationwide USA",
      "state": "IL",
      "product_description": "Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08",
      "report_date": "20180829",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",
      "recall_number": "D-1112-2018",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "80802",
      "termination_date": "20200626",
      "more_code_info": "",
      "recall_initiation_date": "20180814",
      "postal_code": "61103-1201",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}